HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 177 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,730,994 | +44.2% | 71,492 | +36.2% | 0.01% | +25.0% |
| Q2 2023 | $1,893,675 | -23.5% | 52,500 | -74.4% | 0.01% | -65.2% |
| Q3 2016 | $2,477,000 | +322.0% | 205,062 | +230.9% | 0.02% | +283.3% |
| Q1 2016 | $587,000 | -86.6% | 61,966 | -75.5% | 0.01% | -86.7% |
| Q4 2015 | $4,386,000 | +4.3% | 253,063 | -19.2% | 0.04% | -4.3% |
| Q3 2015 | $4,207,000 | +2723.5% | 313,231 | +1566.1% | 0.05% | +2250.0% |
| Q2 2013 | $149,000 | – | 18,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,305,403 | $233,209,000 | 10.86% |
| BB BIOTECH AG | 7,379,832 | $89,148,000 | 3.13% |
| SENZAR ASSET MANAGEMENT, LLC | 550,544 | $6,650,572,000 | 1.72% |
| SNYDER CAPITAL MANAGEMENT L P | 2,232,114 | $26,964,000 | 1.69% |
| Sterling Global Strategies LLC | 22,000 | $266,000 | 0.98% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 9,290,024 | $112,223,000 | 0.98% |
| MSD Partners, L.P. | 965,000 | $11,657,000 | 0.94% |
| DOHENY ASSET MANAGEMENT /CA | 130,950 | $1,582,000 | 0.81% |
| Taylor Wealth Management Partners | 128,110 | $1,548,000 | 0.69% |
| Bellevue Group AG | 318,000 | $3,841,000 | 0.69% |